Bionomics EPS - Earnings per Share 2022-2024 | NEUP
Bionomics eps - earnings per share from 2022 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Bionomics Annual EPS |
| 2024 |
$-1.55 |
| 2023 |
$-2.62 |
| 2022 |
$-2.61 |
| 2021 |
$-1.35 |
| Bionomics Quarterly EPS |
| 2024-09-30 |
$0.00 |
| 2024-06-30 |
$0.00 |
| 2023-12-31 |
$0.00 |
| 2023-09-30 |
$0.00 |
| 2023-06-30 |
$0.00 |
| 2022-12-31 |
$0.00 |
| 2022-06-30 |
$0.00 |
| 2021-06-30 |
$0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.010B |
$0.000B |
|
Bionomics Limited is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders. Bionomics Limited is based in ADELAIDE, Australia.
|
